12 Health Care Stocks Moving In Monday's After-Market Session

周一盘后交易时段，12只医疗保健股走势

Benzinga · 2023/11/20 16:31

NGM Biopharmaceuticals (NASDAQ:NGM) stock moved upwards by 11.5% to $0.7 during Monday's after-market session. This security traded at a volume of 109.4K shares come close, making up 23.4% of its average volume over the last 100 days. The company's market cap stands at $57.8 million.
TC BioPharm (Holdings) (NASDAQ:TCBP) stock increased by 11.24% to $0.58. At the close, TC BioPharm (Holdings)'s trading volume reached 265.9K shares. This is 294.2% of its average volume over the last 100 days. The company's market cap stands at $5.4 million.
Nemaura Medical (NASDAQ:NMRD) shares rose 8.08% to $0.26. The company's market cap stands at $7.3 million.
Exagen (NASDAQ:XGN) stock moved upwards by 7.54% to $1.71. The market value of their outstanding shares is at $28.9 million.
NanoVibronix (NASDAQ:NAOV) shares rose 6.92% to $1.39. The market value of their outstanding shares is at $6.3 million.
Allarity Therapeutics (NASDAQ:ALLR) stock rose 6.0% to $0.53. The market value of their outstanding shares is at $2.2 million. As per the press release, Q3 earnings came out 4 days ago.

Alzamend Neuro (NASDAQ:ALZN) shares decreased by 19.4% to $1.12 during Monday's after-market session. Alzamend Neuro's trading volume hit 2.7 million shares by close, accounting for 13294.1% of its average volume over the last 100 days. The market value of their outstanding shares is at $7.2 million.
Gain Therapeutics (NASDAQ:GANX) shares fell 16.37% to $2.3. The company's market cap stands at $29.2 million. As per the news, the Q3 earnings report came out 4 days ago.
Acutus Medical (NASDAQ:AFIB) shares declined by 16.04% to $0.29. Today's trading volume for this security ended up closing at 399.7K shares, which is 117.1 percent of its average volume over the last 100 days. The market value of their outstanding shares is at $8.4 million.
AVITA Medical (NASDAQ:RCEL) shares declined by 11.2% to $11.11. The market value of their outstanding shares is at $283.8 million.
Vicarious Surgical (NYSE:RBOT) stock decreased by 10.67% to $0.37. The company's market cap stands at $64.4 million.
Forte Biosciences (NASDAQ:FBRX) shares declined by 9.77% to $0.44. The company's market cap stands at $15.9 million. See Also:

This article was generated by Benzinga's automated content engine and reviewed by an editor.

NGM Biopharmaceuticals (NASDAQ:NGM) stock moved upwards by 11.5% to $0.7 during Monday's after-market session. This security traded at a volume of 109.4K shares come close, making up 23.4% of its average volume over the last 100 days. The company's market cap stands at $57.8 million.
TC BioPharm (Holdings) (NASDAQ:TCBP) stock increased by 11.24% to $0.58. At the close, TC BioPharm (Holdings)'s trading volume reached 265.9K shares. This is 294.2% of its average volume over the last 100 days. The company's market cap stands at $5.4 million.
Nemaura Medical (NASDAQ:NMRD) shares rose 8.08% to $0.26. The company's market cap stands at $7.3 million.
Exagen (NASDAQ:XGN) stock moved upwards by 7.54% to $1.71. The market value of their outstanding shares is at $28.9 million.
NanoVibronix (NASDAQ:NAOV) shares rose 6.92% to $1.39. The market value of their outstanding shares is at $6.3 million.
Allarity Therapeutics (NASDAQ:ALLR) stock rose 6.0% to $0.53. The market value of their outstanding shares is at $2.2 million. As per the press release, Q3 earnings came out 4 days ago.

在周一的盘后交易中，NGM Biopharmaceuticals（纳斯达克股票代码：NGM）股价上涨11.5％，至0.7美元。该证券的交易量接近10.94万股，占过去100天平均交易量的23.4％。该公司的市值为5,780万美元。
TC BioPharm（控股）（纳斯达克股票代码：TCBP）股价上涨11.24％，至0.58美元。收盘时，TC BioPharm（控股）的交易量达到26.59万股。这是其过去 100 天平均交易量的294.2％。该公司的市值为540万美元。
Nemaura Medical（纳斯达克股票代码：NMRD）股价上涨8.08％，至0.26美元。该公司的市值为730万美元。
Exagen（纳斯达克股票代码：XGN）股价上涨7.54％，至1.71美元。他们流通股的市值为2890万美元。
NanoVibronix（纳斯达克股票代码：NAOV）股价上涨6.92％，至1.39美元。他们流通股的市值为630万美元。
Allarity Therapeutics（纳斯达克股票代码：ALLR）股价上涨6.0％，至0.53美元。他们流通股的市值为220万美元。根据新闻稿，第三季度财报是在4天前发布的。

Alzamend Neuro (NASDAQ:ALZN) shares decreased by 19.4% to $1.12 during Monday's after-market session. Alzamend Neuro's trading volume hit 2.7 million shares by close, accounting for 13294.1% of its average volume over the last 100 days. The market value of their outstanding shares is at $7.2 million.
Gain Therapeutics (NASDAQ:GANX) shares fell 16.37% to $2.3. The company's market cap stands at $29.2 million. As per the news, the Q3 earnings report came out 4 days ago.
Acutus Medical (NASDAQ:AFIB) shares declined by 16.04% to $0.29. Today's trading volume for this security ended up closing at 399.7K shares, which is 117.1 percent of its average volume over the last 100 days. The market value of their outstanding shares is at $8.4 million.
AVITA Medical (NASDAQ:RCEL) shares declined by 11.2% to $11.11. The market value of their outstanding shares is at $283.8 million.
Vicarious Surgical (NYSE:RBOT) stock decreased by 10.67% to $0.37. The company's market cap stands at $64.4 million.
Forte Biosciences (NASDAQ:FBRX) shares declined by 9.77% to $0.44. The company's market cap stands at $15.9 million. See Also:

在周一的盘后交易中，Alzamend Neuro（纳斯达克股票代码：ALZN）股价下跌19.4％，至1.12美元。Alzamend Neuro的交易量收盘时达到270万股，占其过去100天平均成交量的13294.1％。他们流通股的市值为720万美元。
Gain Therapeutics（纳斯达克股票代码：GANX）股价下跌16.37％，至2.3美元。该公司的市值为2920万美元。根据消息，第三季度收益报告是在4天前发布的。
Acutus Medical（纳斯达克股票代码：AFIB）股价下跌16.04％，至0.29美元。该证券今天的交易量最终收于39.97万股，占其过去100天平均交易量的117.1％。他们流通股的市值为840万美元。
AVITA Medical（纳斯达克股票代码：RCEL）股价下跌11.2％，至11.11美元。他们流通股的市值为2.838亿美元。
Vicarious Surgical（纽约证券交易所代码：RBOT）股价下跌10.67％，至0.37美元。该公司的市值为6,440万美元。
Forte Biosciences（纳斯达克股票代码：FBRX）股价下跌9.77％，至0.44美元。该公司的市值为1,590万美元。另见：

This article was generated by Benzinga's automated content engine and reviewed by an editor.

本文由Benzinga的自动内容引擎生成，并由编辑审阅。

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。更多信息

风险及免责提示